115 related articles for article (PubMed ID: 28472608)
1. Epigenetic regulation of voltage-gated potassium ion channel molecule Kv1.3 in mechanisms of colorectal cancer.
He T; Wang C; Zhang M; Zhang X; Zheng S; Linghu E; Guo M
Discov Med; 2017 Mar; 23(126):155-162. PubMed ID: 28472608
[TBL] [Abstract][Full Text] [Related]
2. Methylation of
Zheng R; Gao D; He T; Zhang M; Zhang X; Linghu E; Wei L; Guo M
Clin Epigenetics; 2017; 9():50. PubMed ID: 28491151
[TBL] [Abstract][Full Text] [Related]
3. Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth.
Wang Y; He T; Herman JG; Linghu E; Yang Y; Fuks F; Zhou F; Song L; Guo M
Clin Epigenetics; 2017; 9():115. PubMed ID: 29075358
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.
Yan W; Wu K; Herman JG; Xu X; Yang Y; Dai G; Guo M
Clin Epigenetics; 2018; 10():69. PubMed ID: 29796120
[TBL] [Abstract][Full Text] [Related]
5. Methylation of TMEM176A is an independent prognostic marker and is involved in human colorectal cancer development.
Gao D; Han Y; Yang Y; Herman JG; Linghu E; Zhan Q; Fuks F; Lu ZJ; Guo M
Epigenetics; 2017 Jul; 12(7):575-583. PubMed ID: 28678648
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing BCL6B induced colorectal cancer proliferation and metastasis by inhibiting P53 signaling.
Hu S; Cao B; Zhang M; Linghu E; Zhan Q; Brock MV; Herman JG; Mao G; Guo M
Am J Cancer Res; 2015; 5(2):651-62. PubMed ID: 25973304
[TBL] [Abstract][Full Text] [Related]
7. WNT5A Promoter Methylation Is Associated with Better Responses and Longer Progression-Free Survival in Colorectal Cancer Patients Treated with 5-Fluorouracil-Based Chemotherapy.
Jiang G; Lin J; Wang W; Sun M; Chen K; Wang F
Genet Test Mol Biomarkers; 2017 Feb; 21(2):74-79. PubMed ID: 28051879
[TBL] [Abstract][Full Text] [Related]
8. Van-Gogh-like 2 antagonises the canonical WNT pathway and is methylated in colorectal cancers.
Piazzi G; Selgrad M; Garcia M; Ceccarelli C; Fini L; Bianchi P; Laghi L; D'Angelo L; Paterini P; Malfertheiner P; Chieco P; Boland CR; Bazzoli F; Ricciardiello L
Br J Cancer; 2013 Apr; 108(8):1750-6. PubMed ID: 23579212
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of PTPRH (Sap-1) in colorectal tumors.
Bujko M; Kober P; Statkiewicz M; Mikula M; Grecka E; Rusetska N; Ligaj M; Ostrowski J; Siedlecki JA
Int J Oncol; 2017 Sep; 51(3):841-850. PubMed ID: 28713969
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of NDRG2 promotes colorectal cancer proliferation and invasion.
Hong SN; Kim SJ; Kim ER; Chang DK; Kim YH
J Gastroenterol Hepatol; 2016 Jan; 31(1):164-71. PubMed ID: 26250123
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic silencing of NTSR1 is associated with lateral and noninvasive growth of colorectal tumors.
Kamimae S; Yamamoto E; Kai M; Niinuma T; Yamano HO; Nojima M; Yoshikawa K; Kimura T; Takagi R; Harada E; Harada T; Maruyama R; Sasaki Y; Tokino T; Shinomura Y; Sugai T; Imai K; Suzuki H
Oncotarget; 2015 Oct; 6(30):29975-90. PubMed ID: 26334593
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide screening for methylation-silenced genes in colorectal cancer.
Khamas A; Ishikawa T; Mogushi K; Iida S; Ishiguro M; Tanaka H; Uetake H; Sugihara K
Int J Oncol; 2012 Aug; 41(2):490-6. PubMed ID: 22664866
[TBL] [Abstract][Full Text] [Related]
13. Deregulation of 2 potassium channels in pancreas adenocarcinomas: implication of KV1.3 gene promoter methylation.
Brevet M; Fucks D; Chatelain D; Regimbeau JM; Delcenserie R; Sevestre H; Ouadid-Ahidouch H
Pancreas; 2009 Aug; 38(6):649-54. PubMed ID: 19465885
[TBL] [Abstract][Full Text] [Related]
14. Promoter Methylation Analysis Reveals That KCNA5 Ion Channel Silencing Supports Ewing Sarcoma Cell Proliferation.
Ryland KE; Hawkins AG; Weisenberger DJ; Punj V; Borinstein SC; Laird PW; Martens JR; Lawlor ER
Mol Cancer Res; 2016 Jan; 14(1):26-34. PubMed ID: 26573141
[TBL] [Abstract][Full Text] [Related]
15. Methylation status of T-lymphoma invasion and metastasis 1 promoter and its overexpression in colorectal cancer.
Jin H; Li T; Ding Y; Deng Y; Zhang W; Yang H; Zhou J; Liu C; Lin J; Ding Y
Hum Pathol; 2011 Apr; 42(4):541-51. PubMed ID: 21237486
[TBL] [Abstract][Full Text] [Related]
16. ATM mutations and E-cadherin expression define sensitivity to EGFR-targeted therapy in colorectal cancer.
Geißler AL; Geißler M; Kottmann D; Lutz L; Fichter CD; Fritsch R; Weddeling B; Makowiec F; Werner M; Lassmann S
Oncotarget; 2017 Mar; 8(10):17164-17190. PubMed ID: 28199979
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic silencing of CXCL14 induced colorectal cancer migration and invasion.
Cao B; Yang Y; Pan Y; Jia Y; Brock MV; Herman JG; Guo M
Discov Med; 2013 Oct; 16(88):137-47. PubMed ID: 24099668
[TBL] [Abstract][Full Text] [Related]
18. MPP3 inactivation by promoter CpG islands hypermethylation in colorectal carcinogenesis.
Feng X; Chen K; Ye S; Wang H; Wei G; Tan W; Cheng S; Zhang Y; Liu S; Zhou Y
Cancer Biomark; 2012; 11(2-3):99-106. PubMed ID: 23011156
[TBL] [Abstract][Full Text] [Related]
19. Altered regulation of DNA ligase IV activity by aberrant promoter DNA methylation and gene amplification in colorectal cancer.
Kuhmann C; Li C; Kloor M; Salou M; Weigel C; Schmidt CR; Ng LW; Tsui WW; Leung SY; Yuen ST; Becker N; Weichenhan D; Plass C; Schmezer P; Chan TL; Popanda O
Hum Mol Genet; 2014 Apr; 23(8):2043-54. PubMed ID: 24282031
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress causes epigenetic alteration of CDX1 expression in colorectal cancer cells.
Zhang R; Kang KA; Kim KC; Na SY; Chang WY; Kim GY; Kim HS; Hyun JW
Gene; 2013 Jul; 524(2):214-9. PubMed ID: 23618814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]